MOTUS THERAPEUTICS
Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.
MOTUS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.motustx.com
Total Employee:
11+
Status:
Active
Contact:
857-264-4280
Email Addresses:
[email protected]
Total Funding:
95.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Amazon Sectigo SSL Sectigo Domain SSL CloudFront Google Adsense AWS Global Accelerator
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
![]()
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List

Current Employees Featured

![]()
![]()
Founder
![]()
![]()
Investors List
![]()
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Motus Therapeutics
MPM Capital
MPM Capital investment in Series B - Motus Therapeutics
![]()
Ipsen
Ipsen investment in Series B - Motus Therapeutics
![]()
Third Rock Ventures
Third Rock Ventures investment in Series B - Motus Therapeutics
![]()
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Motus Therapeutics
![]()
New Enterprise Associates
New Enterprise Associates investment in Series B - Motus Therapeutics
![]()
Third Rock Ventures
Third Rock Ventures investment in Series B - Motus Therapeutics
![]()
New Enterprise Associates
New Enterprise Associates investment in Series B - Motus Therapeutics
MPM Capital
MPM Capital investment in Series B - Motus Therapeutics
![]()
Ipsen
Ipsen investment in Series B - Motus Therapeutics
